PDGF β-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL

Endocrinology

Volumn 151, Issue 9, 2010, Pages 4356-4367

  Getachew, Robel ^a   Ballinger, Mandy L ^a,f   Burch, Micah L ^a,b   Reid, Julianne J ^c   Khachigian, Levon M ^d   Wight, Thomas N ^e   Little, Peter J ^a,b   Osman, Narin ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e BENAROYA RESEARCH INSTITUTE   (United States)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BIGLYCAN; ELONGATION FACTOR; GLYCOSAMINOGLYCAN; IMATINIB; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEOGLYCAN; TYROSINE KINASE RECEPTOR; BENZAMIDE DERIVATIVE; BGN PROTEIN, HUMAN; BGN PROTEIN, MOUSE; FAT INTAKE; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR; PROTEIN BINDING; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AUTOPHOSPHORYLATION; DOWNSTREAM PROCESSING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ADMINISTRATION AND DOSAGE; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTA; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FAT INTAKE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; APOLIPOPROTEINS E; CELLS, CULTURED; DIETARY FATS; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOSAMINOGLYCANS; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PIPERAZINES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTEOGLYCANS; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA INTERFERENCE; BENZAMIDES; BIGLYCAN;

EID: 77956025436     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0027     Document Type: Article

References (44)

1. Williams KJ, Tabas I 1995 The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15:551-561
2. Skålén K, Gustafsson M, Rydberg EK, Hultén LM, Wiklund O, Innerarity TL, Borén J 2002 Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417:750-754 (Pubitemid 34640629)
3. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K 2007 Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 27:1159-1165
4. Ballinger ML, Ivey ME, Osman N, Thomas WG, Little PJ 2009 Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL. Atherosclerosis 205:451-457
5. Dadlani H, Ballinger ML, Osman N, Getachew R, Little PJ 2008 Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle. J Biol Chem 283:7844-7852
6. Ivey ME, Little PJ 2008 Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways. Thromb Res 123:288-297
7. Heldin CH, Westermark B 1999 Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-1316 (Pubitemid 29473317)
8. Libby P, Warner SJ, Salomon RN, Birinyi LK 1988 Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med 318:1493-1498
9. Rubin K, Tingstrom A, Hansson GK, Larsson E, Ronnstrand L, Klareskog L, Claesson-Welsh L, Heldin CH, Fellstrom B, Terracio L 1988 Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet 1:1353-1356
10. Ross R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
11. Schönherr E, Järveläinen HT, Kinsella MG, Sandell LJ, Wight TN 1993 Platelet-derived growth factor and transforming growth factor-β 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler Thromb 13:1026-1036
12. Little PJ, Tannock L, Olin KL, Chait A, Wight TN 2002 Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-β1 exhibit increased binding to LDLs. Arterioscler Thromb Vasc Biol 22:55-60
13. Figueroa JE, Vijayagopal P 2002 Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties. Atherosclerosis 162:261-268
14. Chang MY, Potter-Perigo S, Tsoi C, Chait A, Wight TN 2000 Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem 275:4766-4773 (Pubitemid 30108866)
15. Olsson M, Thyberg J, Nilsson J 1999 Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 19:1218-1222
16. Neylon CB, Little PJ, Cragoe Jr EJ, Bobik A 1990 Intracellular pH in human arterial smooth muscle. Regulation by Na+/H+ exchange and a novel 5-(N-ethyl-N-isopropyl)amiloride-sensitive Na(+)- and HCO3(-)-dependent mechanism. Circ Res 67:814-825
17. Nigro J, Dilley RJ, Little PJ 2002 Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells. Atherosclerosis 162:119-129
18. Schönherr E, Järveläinen HT, Sandell LJ, Wight TN 1991 Effects of platelet-derived growth factor and transforming growth factor-β 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 266:17640-17647
19. Nigro J, Ballinger ML, Dilley RJ, Jennings GL, Wight TN, Little PJ 2004 Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces LDL binding. Diabetologia 47:2105-2113
20. Wasteson A 1971 A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. J Chromatogr 59:87-97
21. Heinecke JW, Baker L, Rosen H, Chait A 1986 Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest 77:757-761 (Pubitemid 16067946)
22. Getachew R, Ballinger ML, Burch ML, Little PJ, Osman N 2010 Characterisation of Ki11502 as a potent inhibitor of PDGF β receptor-mediated proteoglycan synthesis in vascular smooth muscle cells. Eur J Pharmacol 626:186-192
23. Ballinger ML, Nigro J, Frontanilla KV, Dart AM, Little PJ 2004 Regulation of glycosaminoglycan structure and atherogenesis. Cell Mol Life Sci 61:1296-1306
24. Matsui T 1991 Two platelet-derived growth factor receptors in vascular smooth muscle cells. Jpn Circ J 55:1027-1035
25. Fritz TA, Esko JD 2001 Xyloside priming of glycosaminoglycan biosynthesis and inhibition of proteoglycan assembly. In: Iozzo RV, ed. Proteoglycan protocols. Totowa, NJ: Humana Press, Inc.; 317-324
26. Potter-Perigo S, Braun KR, Schönherr E, Wight TN 1992 Altered proteoglycan synthesis via the false acceptor pathway can be dissociated from β-D-xyloside inhibition of proliferation. Arch Biochem Biophys 297:101-109
27. Ballinger ML, Osman N, Hashimura K, de Hann J, Jandeleit-Dahm K, Allen TJ, Tannock LR, Rutledge JC, Little PJ 14 September 2009 Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. J Cell Mol Med 10.1111/j.1582-4934.2009. 00902.x
28. Liu J, Fitzli D, Liu M, Tseu I, Caniggia I, Rotin D, Post M 1998 PDGF-induced glycosaminoglycan synthesis is mediated via phosphatidylinositol 3-kinase. Am J Physiol 274:L702-L713
29. Graf K, Xi XP, Hsueh WA, Law RE 1997 Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells. FEBS Letters 400:119-121
30. Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H, Iwao H 2003 Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 23:795-801
31. Domenzain-Reyna C, Hernández D, Miquel-Serra L, Docampo MJ, Badenas C, Fabra A, Bassols A 2009 Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells. J Biol Chem 284:12306-12317
32. Tan NY, Khachigian LM 2009 Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 29:2483-2488
33. Raines EW 2004 PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15:237-254
34. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R 1994 Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 93:1266-1274
35. Schönherr E, Kinsella MG, Wight TN 1997 Genistein selectively inhibits platelet-derived growth factor- stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch Biochem Biophys 339:353-361 (Pubitemid 27199980)
36. Yang SN, Burch ML, Getachew R, Ballinger ML, Osman N, Little PJ 2009 Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation. Arch Physiol Biochem 115:147-154
37. Caniggia I, Post M 1992 Differential effect of platelet-derived growth factor on glycosaminoglycan synthesis by fetal rat lung cells. Am J Physiol 263:L495-L500
38. Cartel NJ, Liu J, Wang J, Post M 2001 PDGF-BB-mediated activation of p42(MAPK) is independent of PDGF β-receptor tyrosine phosphorylation. Am J Physiol Lung Cell Mol Physiol 281:L786-L798
39. Milanini-Mongiat J, Pouysségur J, Pagès G 2002 Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639
40. Staels B 2002 Cardiovascular biology: a cholesterol tether. Nature 417:699-701
41. Gulberti S, Lattard V, Fondeur M, Jacquinet JC, Mulliert G, Netter P, Magdalou J, Ouzzine M, Fournel-Gigleux S 2005 Modifications of the glycosaminoglycan-linkage region of proteoglycans: phosphorylation and sulfation determine the activity of the human β1,4-galactosyltransferase 7 and β1,3-glucuronosyltransferase I. TSWJ 5:510-514
42. Toma L, Pinhal MA, Dietrich CP, Nader HB, Hirschberg CB 1996 Transport of UDP-galactose into the Golgi lumen regulates the biosynthesis of proteoglycans. J Biol Chem 271:3897-3901 (Pubitemid 26065712)
43. Gustafsson M, Levin M, Skålén K, Perman J, Fridén V, Jirholt P, Olofsson SO, Fazio S, Linton MF, Semenkovich CF, Olivecrona G, Borén J 2007 Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Circ Res 101:777-783
44. Fisher LW, Termine JD, Young MF 1989 Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576